Overview Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma Status: Completed Trial end date: 2012-02-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the safety, tolerability and clinical activity of ASM-024 in stable moderate asthma. Phase: Phase 2 Details Lead Sponsor: Asmacure Ltée